Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,548,599 papers from all fields of science
Search
Sign In
Create Free Account
PCH Regimen
Known as:
Paclitaxel-Carboplatin-Herceptin Regimen
A sequential regimen consisting of carboplatin and paclitaxel, followed by trastuzumab, used in the adjuvant setting for the treatment of HER-2/neu…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Carboplatin
HER2 Positive Breast Carcinoma
Paclitaxel
trastuzumab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
[Pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis: A case report and literature review].
Xianliang Xiong
,
T. Zhu
,
Jiang Li
Zhong nan da xue xue bao. Yi xue ban = Journal of…
2018
Corpus ID: 47006905
Pulmonary veno-occlusive disease (PVOD)/pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary vascular disease…
Expand
Review
2012
Review
2012
Spotlight on Trastuzumab in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer
G. Plosker
,
S. Keam
BioDrugs
2012
Corpus ID: 1027390
Trastuzumab (Herceptin®) is a humanized monoclonal antibody used in the treatment of breast cancer that overexpresses human…
Expand
2012
2012
Uma Análise da Implementação do Programa Minas PCH: O Caso da PCH Cachoeirão Implementation of the Small Hydroelectric Plants Program in Minas Gerais: The Case of the Cachoeirão Plant
Ana Cláudia
,
Pedrosa de Oliveira
,
Simone Martins
,
Suely de Fátima
,
Ramos Silveira
2012
Corpus ID: 112916601
The implementation of government programs is often held responsible for the failure of governments to achieve objectives…
Expand
2011
2011
Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer
O. Abulkhair
,
Wael El Melouk
Case Reports in Oncology
2011
Corpus ID: 1431076
Pneumonitis is a rare but serious complication associated with paclitaxel and/or trastuzumab treatment. We report a 51-year-old…
Expand
2011
2011
Método para la evaluación de los recursos hidroenergéticos en pequeña escala
Ramiro Ortiz Flórez
2011
Corpus ID: 131401134
The current paper seeks to describe a small-scale hydro-energetic resources assessment method as a function of social and…
Expand
Review
2010
Review
2010
Recent Advancements in the Use of Antibody Drug Conjugates for Cancer Therapy
P. Senter
2010
Corpus ID: 67954776
Monoclonal antibodies (mAbs) have demonstrated considerable utility in the clinical treatment of cancer (Reichert et al. 2005…
Expand
2004
2004
Lymphocyte NF-kB and demands of illness measures from women with stage II-IV breast cancer during a complementary yoga intervention
M. A. Crowe
2004
Corpus ID: 42285851
by Michelle A. Crowe, M.S. Washington State University May 2004 Chair: Sally E. Blank Breast cancer survivors are challenged by…
Expand
2002
2002
Emerging technologies for HER2 testing.
M. V. Vijver
2002
Corpus ID: 73087525
HER2-positive status is the sole criterion for identifying patients with breast cancer for Herceptin® therapy, which has known…
Expand
2002
2002
Emerging Technologies for HER2 Testing
M. J. van de Vijver
Oncology
2002
Corpus ID: 41200784
HER2-positive status is the sole criterion for identifying patients with breast cancer for Herceptin® therapy, which has known…
Expand
2001
2001
A cost-effectiveness analysis of Herceptin® (trastuzumab) in combination with Paclitaxel as a first line treatment for HER2 positive (3+) Metastatic Breast Cancer (MBC) patients in the UK
A. Ratcliffe
,
C. Poole
,
D. Miles
2001
Corpus ID: 71280646
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE